This Page Intentionally Left Blank - Int Medical

108 Arthritis
38. Curtis SP, Ko AT, Bolognese JA, et al. Pooled analysis of thrombotic cardiovascular
events in clinical trials of the COX-2 selective Inhibitor etoricoxib.
Curr Med Res Opin. 2006;22:2365–2374.
39. Zhang W, Doherty M, Leeb BF, et al. EULAR evidence based recommendations
for the management of hand osteoarthritis: report of a Task Force of the
EULAR Standing Committee for International Clinical Studies Including
Therapeutics (ESCISIT). Ann Rheum Dis. 2007;66:377–388.
40. Moskowitz RW, Sunshine A, Hooper M, et al. An analgesic model for assessment
of acute pain response in osteoarthritis of the knee. Osteoarthritis
Cartilage. 2006;14:1111–1118.
41. Sheldon E, Beaulieu A, Paster Z, et al. Efficacy and tolerability of lumiracoxib
in the treatment of osteoarthritis of the knee: a 13-week, randomized,
double-blind comparison with celecoxib and placebo. Clin Ther.
2005;27:64–77.
42. Berenbaum F, Grifka J, Brown JP, et al. Efficacy of lumiracoxib in osteoarthritis:
a review of nine studies. J Int Med Res. 2005;33:21–41.
43. Wittenberg RH, Schell E, Krehan G, et al. First-dose analgesic effect of the
cyclo-oxygenase-2 selective inhibitor lumiracoxib in osteoarthritis of the
knee: a randomized, double-blind, placebo-controlled comparison with
celecoxib (NCT00267215). Arthritis Res Ther. 2006;8:R35.
44. Fenton C, Keating GM, Wagstaff AJ. Valdecoxib: a review of its use in the
management of osteoarthritis, rheumatoid arthritis, dysmenorrhoea and
acute pain. Drugs. 2004;64:1231–1261.
45. Rainsford KD. Current status of the therapeutic uses and actions of the
preferential cyclo-oxygenase-2 NSAID, nimesulide. Inflammopharmacology.
2006;14:120–137.
46. Pareek A, Chandanwale AS, Oak J, et al. Efficacy and safety of aceclofenac in the
treatment of osteoarthritis: a randomized double-blind comparative clinical trial
versus diclofenac – an Indian experience. Curr Med Res Opin. 2006;22:977–988.
47. Hamburger MI, Lakhanpal S, Mooar PA, et al. Intra-articular hyaluronans:
a review of product-specific safety profiles. Semin Arthritis Rheum.
2003;32:296–309.
48. Hammesfahr JF, Knopf AB, Stitik T. Safety of intra-articular hyaluronates for pain
associated with osteoarthritis of the knee. Am J Orthop. 2003;32:277–283.
49. Zhang DW, Yang QS, Zhu JY, et al. Amelioration of osteoarthritis by intraarticular
hyaluronan synthase 2 gene therapy. Med Hypotheses. 2007;
69:1111–1113.